OSCI Insider Trading Activity and SEC Form 4 Filings
OSCI insider trading summary
No open-market insider purchases or sales of Oscient Pharmaceuticals Corp (OSCI) have been reported on SEC Form 4 in the past 12 months.
Latest OSCI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 21, 2009 | GLG Partners LP | 10% Owner | Sell | $237K (785,616 @ $0.30) |
| May 21, 2009 | GLG Market Neutral Fund | 10% Owner | Sell | $237K (785,616 @ $0.30) |
| May 21, 2009 | GLG Partners LTD | 10% Owner | Sell | $237K (785,616 @ $0.30) |
| May 21, 2009 | GLG Partners, Inc. | 10% Owner | Sell | $237K (785,616 @ $0.30) |
| May 14, 2009 | DellaCamera Capital Management, LLC | 10% Owner | Sell | $98K (468,230 @ $0.21) |
| May 13, 2009 | DellaCamera Capital Management, LLC | 10% Owner | Sell | $25K (108,162 @ $0.23) |
| May 13, 2009 | DellaCamera Capital Management, LLC | 10% Owner | Sell | $104K (416,391 @ $0.25) |
| May 8, 2009 | DellaCamera Capital Management, LLC | 10% Owner | Sell | $27K (100,325 @ $0.27) |
| Apr 1, 2009 | DellaCamera Capital Management, LLC | 10% Owner | Sell | $9K (70,000 @ $0.13) |
| Mar 31, 2009 | DellaCamera Capital Management, LLC | 10% Owner | Sell | $19K (150,000 @ $0.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.